Canada markets open in 5 hours 43 minutes

BriaCell Therapeutics Corp. (BCTX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.1476-0.0124 (-0.57%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 34.23M
Enterprise Value 27.99M
Trailing P/E 719.00
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)17.03
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.97

Trading Information

Stock Price History

Beta (5Y Monthly) 1.75
52-Week Change 3-70.75%
S&P500 52-Week Change 321.23%
52 Week High 37.5900
52 Week Low 32.0200
50-Day Moving Average 33.0110
200-Day Moving Average 34.8325

Share Statistics

Avg Vol (3 month) 387.8k
Avg Vol (10 day) 354.49k
Shares Outstanding 515.98M
Implied Shares Outstanding 616.22M
Float 811.64M
% Held by Insiders 112.27%
% Held by Institutions 115.46%
Shares Short (Mar 28, 2024) 4677.91k
Short Ratio (Mar 28, 2024) 46.14
Short % of Float (Mar 28, 2024) 44.84%
Short % of Shares Outstanding (Mar 28, 2024) 44.24%
Shares Short (prior month Feb 29, 2024) 4795.9k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 02, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:300
Last Split Date 3Jan 02, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Jul 31, 2023
Most Recent Quarter (mrq)Jan 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-85.45%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -31.7M
Net Income Avi to Common (ttm)-12.61M
Diluted EPS (ttm)-0.7900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.24M
Total Cash Per Share (mrq)0.39
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.99
Book Value Per Share (mrq)-0.50

Cash Flow Statement

Operating Cash Flow (ttm)-31.26M
Levered Free Cash Flow (ttm)-19.76M